Sarepta Therapeutics Details

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut future...
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing.
Employees
HQ
+1 617-274-4000
Location
Cambridge, Massachusetts
Revenue
$645.6M

Technologies

Content Delivery Networks
Domain Name Services
Email Providers
Hosting

Notable Alumni

Alex Lagadinos
Director, Corporate Business Development
Resilience
Amanda Harring-Abbott
Clinical Operations Program Lead
Biogen
Aria Read
Senior Manager Marketing Operations
Sage Therapeutics
Bella Gorbatcheva
Director, Project Management, Business Strategy
Dewpoint Therapeutics

Employees

GMP Data Associate
Director, Process Development and Scale Up
Director, Regulatory Affairs CMC
Principal Statistical Programmer
Research Associate II

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

"We love the interface, the experience, and most importantly… the results."

Erik Straub

Chief Marketing Officer, Kickfurther

"Using Apollo, we’ve solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects."

Michael Transon

CEO, Victorious

Ready to try it out?

Get started for free, then add your whole team. You can always talk to sales if you’re interested in advanced plans.